Voyager Therapeutics, Inc.

EDGAR

Annual consolidated revenue for 2025: about Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 40.37M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 80M.

Watchlist

Latest quarter

Revenue

3.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-824.75%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -26392000 USD Source
  • Revenue: 3200000 USD Source
Cash and cash equivalents
35.8 million USD Source
Exact value

35769000 USD

Long-term debt including current maturities
Not available
Shares outstanding
61.3 million shares Source
Exact value

61273390 shares

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-21.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 3 of 11 periods available· newest 2025-12-31
  • Net income: 3 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -49.5%

    Prior period

    Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 80 million

    –

    Current period

    Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 40.37 million

    –

    Exact inputs and evidence

    40374000 − 80001000 = -39627000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

    80001000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    40374000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 54.72 million

    Prior period

    −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 65 million

    –

    Current period

    −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 119.72 million

    –

    Exact inputs and evidence

    -119721000 − -65002000 = -54719000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

    -65002000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -119721000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 117.16 million

    Prior period

    −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 15.31 million

    –

    Current period

    −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 132.47 million

    –

    Exact inputs and evidence

    -132467000 − -15310000 = -117157000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

    -15310000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -132467000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -26.3%

    Prior period

    Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 3.52 million

    –

    Current period

    Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 2.6 million

    –

    Exact inputs and evidence

    2596000 − 3521000 = -925000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

    3521000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    2596000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 40.37 million 100% of revenue
  • Operating costs Derived Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 172.22 million 427% of revenue
  • Operating income −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 131.84 million −327% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 12.12 million −30% of revenue
  • Net income −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 119.72 million −297% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 132.47 million −328% of revenue
  • Capital expenditure Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 2.6 million 6.4% of revenue
  • Free cash flow Derived −Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 135.06 million −335% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Net income was higher than operating income, so the split is not drawn.
  • 2024 Operating loss: operating costs were 204% of revenue.
  • 2025 Operating loss: operating costs were 427% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-31250008000 127994000 Derived 122014000 -10316000 Derived 132330000 74663000 Derived
Source
2024 2024-01-01 – 2024-12-3180001000 163288000 Derived -83287000 -18285000 Derived -65002000 -18831000 Derived
Source
2025 2025-01-01 – 2025-12-3140374000 172218000 Derived -131844000 -12123000 Derived -119721000 -135063000 Derived
Source

Amounts are exact, in Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 40.4M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.270.0M202.5M135.0M67.5M0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA)Source evidence
2023Revenue250008000
2024Revenue80001000
2025Revenue40374000

Revenue growth

Change in revenue from the same financial period one year earlier.

-49.5% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5%-14%-34%-54%-73%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year-68%
2025Year over year-49.5%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -326.6% 2025
Net margin -296.5% 2025
Free cash flow margin -334.5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.84%-28%-141%-253%-366%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin48.8%
2024Operating margin-104.1%
2025Operating margin-326.6%
2023Net margin52.9%
2024Net margin-81.3%
2025Net margin-296.5%
2023Free cash flow margin29.9%
2024Free cash flow margin-23.5%
2025Free cash flow margin-334.5%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA -132.5M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.94.7M33.7M-27.3M-88.3M-149.3M202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA)Source evidence
2023Operating cash flow77919000
2024Operating cash flow-15310000
2025Operating cash flow-132467000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA -135.1M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.91.4M30.6M-30.2M-91.0M-151.8M202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA)Source evidence
2023Free cash flow74663000
2024Free cash flow-18831000
2025Free cash flow-135063000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Liabilities / assetsNot reportedNo source recorded
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Current assets / current liabilitiesNot reportedNo source recorded
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 132.33 million
Exact value

Exact value: 132330000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2023-01-01 – 2023-12-31: 132330000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 77.92 million
Exact value

Exact value: 77919000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2023-01-01 – 2023-12-31: 77919000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 3.26 million
Exact value

Exact value: 3256000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2023-01-01 – 2023-12-31: 3256000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 74.66 million
Calculation and evidence

77919000 − 3256000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

Exact free cash flow: 74663000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 65 million
Exact value

Exact value: -65002000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2024-01-01 – 2024-12-31: -65002000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 15.31 million
Exact value

Exact value: -15310000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2024-01-01 – 2024-12-31: -15310000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 3.52 million
Exact value

Exact value: 3521000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2024-01-01 – 2024-12-31: 3521000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 18.83 million
Calculation and evidence

-15310000 − 3521000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

Exact free cash flow: -18831000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 119.72 million
Exact value

Exact value: -119721000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2025-01-01 – 2025-12-31: -119721000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 132.47 million
Exact value

Exact value: -132467000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2025-01-01 – 2025-12-31: -132467000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 2.6 million
Exact value

Exact value: 2596000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

2025-01-01 – 2025-12-31: 2596000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA 135.06 million
Calculation and evidence

-132467000 − 2596000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

Exact free cash flow: -135063000 Unit_Standard_USD_9_oahcRkDEidkgS8kLMUdA

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

64 filings · 5,290 latest values · 5,290 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001640266, 1640266, VYGR, edgar:1640266

Also known as Voyager Therapeutics, Inc., Voyager Therapeutics, Inc.